Chen Xiang, Bahrami Armita, Pappo Alberto, Easton John, Dalton James, Hedlund Erin, Ellison David, Shurtleff Sheila, Wu Gang, Wei Lei, Parker Matthew, Rusch Michael, Nagahawatte Panduka, Wu Jianrong, Mao Shenghua, Boggs Kristy, Mulder Heather, Yergeau Donald, Lu Charles, Ding Li, Edmonson Michael, Qu Chunxu, Wang Jianmin, Li Yongjin, Navid Fariba, Daw Najat C, Mardis Elaine R, Wilson Richard K, Downing James R, Zhang Jinghui, Dyer Michael A
Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Cell Rep. 2014 Apr 10;7(1):104-12. doi: 10.1016/j.celrep.2014.03.003. Epub 2014 Apr 3.
Pediatric osteosarcoma is characterized by multiple somatic chromosomal lesions, including structural variations (SVs) and copy number alterations (CNAs). To define the landscape of somatic mutations in pediatric osteosarcoma, we performed whole-genome sequencing of DNA from 20 osteosarcoma tumor samples and matched normal tissue in a discovery cohort, as well as 14 samples in a validation cohort. Single-nucleotide variations (SNVs) exhibited a pattern of localized hypermutation called kataegis in 50% of the tumors. We identified p53 pathway lesions in all tumors in the discovery cohort, nine of which were translocations in the first intron of the TP53 gene. Beyond TP53, the RB1, ATRX, and DLG2 genes showed recurrent somatic alterations in 29%-53% of the tumors. These data highlight the power of whole-genome sequencing for identifying recurrent somatic alterations in cancer genomes that may be missed using other methods.
儿童骨肉瘤的特征是存在多个体细胞染色体病变,包括结构变异(SVs)和拷贝数改变(CNAs)。为了明确儿童骨肉瘤体细胞突变的全貌,我们对发现队列中的20个骨肉瘤肿瘤样本及其匹配的正常组织的DNA进行了全基因组测序,验证队列中也有14个样本进行了测序。单核苷酸变异(SNVs)在50%的肿瘤中呈现出一种称为kataegis的局部超突变模式。我们在发现队列的所有肿瘤中都鉴定出了p53通路病变,其中9个是TP53基因第一内含子中的易位。除了TP53,RB1、ATRX和DLG2基因在29%-53%的肿瘤中显示出复发性体细胞改变。这些数据凸显了全基因组测序在识别癌症基因组中复发性体细胞改变方面的强大作用,而这些改变可能会被其他方法遗漏。